Dig Howitt’s week from hell a sign of the times for health giants

For decades Cochlear, CSL and ResMed could do no wrong. Those days are over, and a battery of issues has investors ...

Cochlear profit downgrade ‘shocked the market’, shares at 10-year low

The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global sales would hit its bottom line.

Cochlear shares plunge in worst drop for 30 years after profit warning

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on deteriorating global consumer sentiment and the Middle East conflict.

Hearing implant maker Cochlear suffers $4.4b wipeout after downgrading its profit guidance for 2026 financial year

A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share price to a 10-year low.
CNBC

Cochlear: Hopes to return to 70% dividend payout ratio 'as quickly as we can'

Cochlear President Dig Howitt discusses the company's latest results and outlines the conditions for returning to a 70% dividend payout ratio. Got a confidential news tip? We want to hear from you.

Cochlear caught in market’s deadly crocodile roll

The hearing implant maker is fighting a high-stakes battle against market dark arts and an investor exodus that could trigger ...
The Toowoomba Chronicle

Cochlear shares plunge in worst drop for 30 years after profit warning

Cuts to Medicaid legislated by Trump’s One Big Beautiful Bill Act have crippled Cochlear’s American business by restricting coverage for hearing implants. The ASX company said it expected underlying ...